Captrust Financial Advisors Bio Rad Laboratories, Inc. Transaction History

Captrust Financial Advisors

$30.9 Billion
Q2 2024

A detailed history of Captrust Financial Advisors transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 992 shares of BIO stock, worth $327,369. This represents 0.0% of its overall portfolio holdings.

Number of Shares

992

Previous 1,687 41.2%

Holding current value

$327,369

Previous $583,000 53.69%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$268.26 - $339.48 $186,440 - $235,938	-695 Reduced 41.2%	992 $270,000
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $11,252 - $13,023	-37 Reduced 2.15%	1,687 $583,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $26,128 - $35,408	97 Added 5.96%	1,724 $556,000
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $83,359 - $100,585	-238 Reduced 12.76%	1,627 $583,000
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $267,101 - $361,395	743 Added 66.22%	1,865 $707,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $64,896 - $77,965	155 Added 16.03%	1,122 $537,000
Q4 2022 Feb 15, 2023	BUY	$351.71 - $456.01 $68,231 - $88,465	194 Added 25.1%	967 $406,000
Q3 2022 Nov 16, 2022	SELL	$412.59 - $563.26 $3,300 - $4,506	-8 Reduced 1.02%	773 $322,000
Q2 2022 Aug 23, 2022	SELL	$463.67 - $597.16 $153,011 - $197,062	-330 Reduced 29.7%	781 $387,000
Q2 2022 Aug 16, 2022	BUY	$463.67 - $597.16 $175,730 - $226,323	379 Added 51.78%	1,111 $550,000
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $70,816 - $99,281	135 Added 22.61%	732 $412,000
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $63,086 - $70,726	-89 Reduced 12.97%	597 $451,000
Q3 2021 Nov 16, 2021	BUY	$657.71 - $825.77 $26,308 - $33,030	40 Added 6.19%	686 $512,000
Q2 2021 Aug 16, 2021	BUY	$576.64 - $649.04 $26,525 - $29,855	46 Added 7.67%	646 $416,000
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $285,539 - $345,746	522 Added 669.23%	600 $343,000
Q4 2020 Feb 16, 2021	SELL	$510.68 - $643.45 $1,021 - $1,286	-2 Reduced 2.5%	78 $45,000
Q3 2020 Nov 17, 2020	BUY	$454.43 - $535.6 $22,721 - $26,780	50 Added 166.67%	80 $42,000
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $10,046 - $14,791	30 New	30 $14,000
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $1,918 - $2,245	-6 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$220.1 - $309.0 $880 - $1,236	-4 Reduced 40.0%	6 $1,000
Q3 2018 Nov 15, 2018	SELL	$289.28 - $326.15 $51,491 - $58,054	-178 Reduced 94.68%	10 $3,000
Q2 2018 Aug 13, 2018	BUY	$244.1 - $303.88 $2,441 - $3,038	10 Added 5.62%	188 $54,000
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $25,268 - $29,603	-108 Reduced 37.76%	178 $44,000
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $62,044 - $77,591	286	286 $68,000

Others Institutions Holding BIO

# of Institutions

460

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.13B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Bio Rad Laboratories, Inc. Transaction History